News
A new artificial intelligence model can improve the process of drug and vaccine discovery by predicting how efficiently ...
19h
News-Medical.Net on MSNNew model predicts mRNA protein production, accelerating drug and vaccine discovery
A new artificial intelligence model can improve the process of drug and vaccine discovery by predicting how efficiently ...
2d
MedPage Today on MSNKennedy's mRNA Moves Anger MAHA Allies; Winning Back NIH Grants; Start-Up Games HSAs
Mary Talley Bowden, MD, founder of Americans for Health Freedom, an advocacy group that has lobbied against mRNA shots, ...
The experimental mRNA vaccine developed at the University of Florida has shown the ability to supercharge the immune system ...
Researchers at the University of Florida have developed a new mRNA-based vaccine that, when combined with checkpoint ...
Here are some studies from just the last couple of weeks — all funded in part by the NIH — that could advance the biopharma ...
What if mRNA vaccines could be made more powerful and less irritating? Scientists at the University of Pennsylvania have ...
2d
Zacks Investment Research on MSNModerna (MRNA) Stock Slides as Market Rises: Facts to Know Before You Trade
Moderna (MRNA) closed at $34.01 in the latest trading session, marking a -1.9% move from the prior day. This change lagged the S&P 500's daily gain of 0.07%. Meanwhile, the Dow lost 0.7%, and the ...
Indeed, mRNA vaccines designed to treat cancer (among other diseases) “are quite realistic,” says Anna Blakney, an RNA researcher at the University of British Columbia.
In this episode presented by Eclipsebio, BioSpace's head of insights Lori Ellis discusses mRNA and srRNA with Andy Geall of ...
Compared to the standard shot, the mRNA vaccine had an overall vaccine efficacy that was 26.6 percent higher, and 27.4 percent higher in participants who were aged 65 years or older. Previous trial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results